BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 26456295)

  • 1. Maltose modified poly(propylene imine) dendrimers as potential carriers of nucleoside analog 5'-triphosphates.
    Szulc A; Signorelli M; Schiraldi A; Appelhans D; Voit B; Bryszewska M; Klajnert-Maculewicz B; Fessas D
    Int J Pharm; 2015 Nov; 495(2):940-7. PubMed ID: 26456295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sugar-modified poly(propylene imine) dendrimers as drug delivery agents for cytarabine to overcome drug resistance.
    Szulc A; Pulaski L; Appelhans D; Voit B; Klajnert-Maculewicz B
    Int J Pharm; 2016 Nov; 513(1-2):572-583. PubMed ID: 27667754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of maltose modified poly(propylene imine) dendrimers on hen egg white lysozyme structure and thermal stability.
    Ciolkowski M; Pałecz B; Appelhans D; Voit B; Klajnert B; Bryszewska M
    Colloids Surf B Biointerfaces; 2012 Jun; 95():103-8. PubMed ID: 22410344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studying complexes between PPI dendrimers and Mant-ATP.
    Szulc A; Appelhans D; Voit B; Bryszewska M; Klajnert B
    J Fluoresc; 2013 Mar; 23(2):349-56. PubMed ID: 23306952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poly(propyleneimine) glycodendrimers non-covalently bind ATP in a pH- and salt-dependent manner - model studies for adenosine analogue drug delivery.
    Gorzkiewicz M; Buczkowski A; Appelhans D; Voit B; Pułaski Ł; Pałecz B; Klajnert-Maculewicz B
    Int J Pharm; 2018 Jun; 544(1):83-90. PubMed ID: 29653214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poly(propylene imine) dendrimers modified with maltose or maltotriose protect phosphorothioate oligodeoxynucleotides against nuclease activity.
    Drzewińska J; Appelhans D; Voit B; Bryszewska M; Klajnert B
    Biochem Biophys Res Commun; 2012 Oct; 427(1):197-201. PubMed ID: 22995301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction study between maltose-modified PPI dendrimers and lipidic model membranes.
    Wrobel D; Appelhans D; Signorelli M; Wiesner B; Fessas D; Scheler U; Voit B; Maly J
    Biochim Biophys Acta; 2015 Jul; 1848(7):1490-501. PubMed ID: 25843678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigations on biodistribution of technetium-99m-labeled carbohydrate-coated poly(propylene imine) dendrimers.
    Agashe HB; Babbar AK; Jain S; Sharma RK; Mishra AK; Asthana A; Garg M; Dutta T; Jain NK
    Nanomedicine; 2007 Jun; 3(2):120-7. PubMed ID: 17572354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicity and proapoptotic activity of poly(propylene imine) glycodendrimers in vitro: considering their contrary potential as biocompatible entity and drug molecule in cancer.
    Ziemba B; Franiak-Pietryga I; Pion M; Appelhans D; Muñoz-Fernández MÁ; Voit B; Bryszewska M; Klajnert-Maculewicz B
    Int J Pharm; 2014 Jan; 461(1-2):391-402. PubMed ID: 24361266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of poly(propylene imine) glycodendrimers on β-amyloid aggregation in vitro and in APP/PS1 transgenic mice, as a model of brain amyloid deposition and Alzheimer's disease.
    Klementieva O; Aso E; Filippini D; Benseny-Cases N; Carmona M; Juvés S; Appelhans D; Cladera J; Ferrer I
    Biomacromolecules; 2013 Oct; 14(10):3570-80. PubMed ID: 24004423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polypropyleneimine and polyamidoamine dendrimer mediated enhanced solubilization of bortezomib: Comparison and evaluation of mechanistic aspects by thermodynamics and molecular simulations.
    Chaudhary S; Gothwal A; Khan I; Srivastava S; Malik R; Gupta U
    Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():611-619. PubMed ID: 28024628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New surface hydroxylated and internally quaternised poly(propylene imine) dendrimers as efficient biocompatible drug carriers of norfloxacin.
    Murugan E; Geetha Rani DP; Srinivasan K; Muthumary J
    Expert Opin Drug Deliv; 2013 Oct; 10(10):1319-34. PubMed ID: 23789895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug delivery investigations of quaternised poly(propylene imine) dendrimer using nimesulide as a model drug.
    Murugan E; Geetha Rani DP; Yogaraj V
    Colloids Surf B Biointerfaces; 2014 Feb; 114():121-9. PubMed ID: 24184533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotoxicity of poly(propylene imine) dendrimers.
    Ziemba B; Matuszko G; Appelhans D; Voit B; Bryszewska M; Klajnert B
    Biopolymers; 2012 Aug; 97(8):642-8. PubMed ID: 22605555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of maltotriose-modified poly(propylene imine) dendrimers on the chronic lymphocytic leukemia cells in vitro: dense shell G4 PPI.
    Franiak-Pietryga I; Ziółkowska E; Ziemba B; Appelhans D; Voit B; Szewczyk M; Góra-Tybor J; Robak T; Klajnert B; Bryszewska M
    Mol Pharm; 2013 Jun; 10(6):2490-501. PubMed ID: 23641871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gd-Chelated poly(propylene imine) dendrimers with densely organized maltose shells for enhanced MR imaging applications.
    Xiong Z; Wang Y; Zhu J; He Y; Qu J; Effenberg C; Xia J; Appelhans D; Shi X
    Biomater Sci; 2016 Oct; 4(11):1622-1629. PubMed ID: 27722500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modified poly(propylene imine) dendrimers as effective transfection agents for catalytic DNA enzymes (DNAzymes).
    Tack F; Bakker A; Maes S; Dekeyser N; Bruining M; Elissen-Roman C; Janicot M; Brewster M; Janssen HM; De Waal BF; Fransen PM; Lou X; Meijer EW
    J Drug Target; 2006 Feb; 14(2):69-86. PubMed ID: 16608734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study on solubility improvement of tetracycline and dexamethasone by poly(propylene imine) and polyamidoamine dendrimers: An insight into cytotoxicity and cell proliferation.
    Najafi F; Salami-Kalajahi M; Roghani-Mamaqani H; Kahaie-Khosrowshahi A
    J Biomed Mater Res A; 2020 Mar; 108(3):485-495. PubMed ID: 31682311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sugar-Modified Poly(propylene imine) Dendrimers Stimulate the NF-κB Pathway in a Myeloid Cell Line.
    Jatczak-Pawlik I; Gorzkiewicz M; Studzian M; Appelhans D; Voit B; Pulaski L; Klajnert-Maculewicz B
    Pharm Res; 2017 Jan; 34(1):136-147. PubMed ID: 27766462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of different generations of poly(propylene imine) dendrimers on human erythrocytes.
    Mishra V; Gupta U; Jain NK
    Pharmazie; 2010 Dec; 65(12):891-5. PubMed ID: 21284258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.